Avalo Therapeutics, Inc. (AVTX): Shares Outstanding
18.51M
As of 2025-12-31
52.90M
As of 2026-06-30
n/m
3-year compound annual growth
-24.4%
5-year compound annual growth
+7.9%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 18.51M | +76.8% | 2026-03-23, Balance as of period end |
| 2024-12-31 | 10.47M | n/m | 2026-03-23, Balance as of period end |
| 2023-12-31 | 801.7K | n/m | 2025-03-20, Balance as of period end |
| 2022-12-31 | 39.3K | -99.6% | 2024-03-29, Balance as of period end |
| 2021-12-31 | 9.40M | -87.5% | 2023-03-29, Balance as of period end |
| 2020-12-31 | 75.00M | +69.0% | 2022-03-02, Balance as of period end |
| 2019-12-31 | 44.38M | +8.8% | 2021-03-08, Balance as of period end |
| 2018-12-31 | 40.80M | +30.5% | 2020-03-11, Balance as of period end |
| 2017-12-31 | 31.27M | +231.4% | 2019-03-18, Balance as of period end |
| 2016-12-31 | 9.43M | +9.1% | 2018-04-02, Balance as of period end |
| 2015-12-31 | 8.65M | n/m | 2017-03-14, Balance as of period end |
| 2014-12-31 | 649.7K | n/a | 2016-03-23, Balance as of period end |